1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base and Forecast Years Timeline
1.8. Key Benefits for the Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Research Process
3. EXECUTIVE SUMMARY
3.1. Key Findings
3.2. Analyst View
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
4.5. Government Agencies Regulations
4.6. Patents and Ongoing Research
4.7. Clinical Trials and Phase Analysis
4.8. Prevalence and Incidence Rate Analysis
5. PERIPHERAL VASCULAR INTERVENTION MARKET BY PRODUCT TYPE
5.1. Introduction
5.2. Stents
5.3. Balloons
5.4. Atherectomy System
5.5. Catheters
5.6. Peripheral Accessories
5.6.1. Guidewires
5.7. Others
6. PERIPHERAL VASCULAR INTERVENTION MARKET BY APPLICATION
6.1. Introduction
6.2. Peripheral Artery Disease
6.3. Deep Vein Thrombosis (DVT)
6.4. Aneurysms
6.5. Venous Disease
6.6. Pulmonary Embolism (PE)
6.7. Others
7. PERIPHERAL VASCULAR INTERVENTION MARKET BY END-USER
7.1. Introduction
7.2. Hospitals
7.3. Ambulatory Surgical Centers
7.4. Others
8. PERIPHERAL VASCULAR INTERVENTION MARKET BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. By Product Type
8.2.2. By Application
8.2.3. By End-User
8.2.4. By Country
8.2.4.1. USA
8.2.4.2. Canada
8.2.4.3. Mexico
8.3. South America
8.3.1. By Product Type
8.3.2. By Application
8.3.3. By End-User
8.3.4. By Country
8.3.4.1. Brazil
8.3.4.2. Argentina
8.3.4.3. Others
8.4. Europe
8.4.1. By Product Type
8.4.2. By Application
8.4.3. By End-User
8.4.4. By Country
8.4.4.1. United Kingdom
8.4.4.2. Germany
8.4.4.3. France
8.4.4.4. Others
8.5. Middle East and Africa
8.5.1. By Product Type
8.5.2. By Application
8.5.3. By End-User
8.5.4. By Country
8.5.4.1. Saudi Arabia
8.5.4.2. UAE
8.5.4.3. Others
8.6. Asia Pacific
8.6.1. By Product Type
8.6.2. By Application
8.6.3. By End-User
8.6.4. By Country
8.6.4.1. China
8.6.4.2. Japan
8.6.4.3. India
8.6.4.4. South Korea
8.6.4.5. Indonesia
8.6.4.6. Thailand
8.6.4.7. Taiwan
8.6.4.8. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Mergers, Acquisitions, Agreements, and Collaborations
9.3. Vendor Matrix
10. COMPANY PROFILES
10.1. Boston Scientific Corporation
10.2. Abbott Laboratories
10.3. BD (Becton, Dickinson and Company)
10.4. Zylox-Tonbridge Medical Technology Co., Ltd.
10.5. BIOTRONIK
10.6. Medtronic
10.7. Terumo Corporation
10.8. B. Braun Melsungen AG
10.9. Cook Medical
10.10. Meril Life Sciences Pvt. Ltd.
10.11. Merit Medical Systems
10.12. Philips
10.13. TE Connectivity
10.14. AngioDynamics